Efficacy of gatifloxacin in pneumococcal respiratory infection

Drugs

Volumn 58, Issue SUPPL. 2, 1999, Pages 280-281

  Soejima, Rinzo ^a   Saito, Atsushi ^b  

^a KAWASAKI UNIVERSITY OF MEDICAL WELFARE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ERYTHROMYCIN; GATIFLOXACIN; LACTAM; LEVOFLOXACIN; MACROLIDE; MINOCYCLINE; PENICILLIN G;

ANTIBIOTIC RESISTANCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS INFECTION;

STREPTOCOCCUS;

EID: 0032706004     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199958002-00092     Document Type: Conference Paper

References (5)

1. Hosaka M, Yasue T, Fukuda H, et al. In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone. Antimicrob Agents Chemother 1992; 36: 2108-17
2. Bauernfeind A. Comparison of antibacterial activities of the quinolones, Bay 12-8039, gatifloxacin (AM-1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin. J Antimicrob Chemother 1997; 40: 639-51
3. Tomizawa H, Tateda K, Miyazaki S, et al. Antibacterial activity of AM-1155 against penicillin-resistant Streptococcus pneumoniae. J Antimicrob Chemother 1998; 41: 103-6
4. Nakashima M, Uematsu T, Kosuge K, et al. Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans. Antimicrob Agents Chemother 1995; 39: 2635-40
5. Ubukata K, Asahi Y, Okuzumi K, et al. Incidence of penicillin-resistant Streptococcus pneumoniae in Japan, 1993-1995. J Infect Chemother 1996; 1: 177-84